Hospital Medicine

VOYAGER PAD subgroup analyses showed the anticoagulant reduced likelihood of hospitalization without increasing bleeding risk in patients with CKD.

Investigators believe the novel monoclonal antibody may be a suitable agent in patients with major bleeding risk or those undergoing surgery.

The NaV1.8 inhibitor VX-548 shows promising potential as a non-opioid acute pain treatment.

Team-based care shows the reduction of multiple risk factors, attainment of multiple treatment targets, and empowerment among high-risk patients with DKD.

RBX2660 is a live microbiome therapeutics that could build on the success of fecal microbiota transplantation for treating patients with recurrent C difficile infections.

Data from Australia show a T-cell antigen-inducing vaccine was unable to provide greater prevention of flu incidence than a placebo.

Large variations were observed in the transition between monotherapy and dual combination therapy for hypertension across countries and demographic group.

Strategies to improve enrollment of underrepresented populations were centered on study design and site selection, community engagement, and changing the research paradigm.

Greater increases were observed among members of racial and ethnic minority groups, with the highest increase among non-Hispanic Black individuals.

Case-control analyses suggest older patients may cognitively age by about 8 years within 6 months of being discharged for severe COVID-19.

The Director of Policy and Advocacy for the US Pain Foundation addresses the important changes made to the updated draft of the CDC Clinical Practical Guideline for Prescribing Opioids 2022.

Cross-sectional analysis of national survey data suggest students with multiple marginalized identities are more prone to treatment that could lead to burnout.

Experts observed a significant increase in monthly overdose deaths during Spring 2020, before a gradual decrease to 2019 rates.

Phase 3 data show the C3 inhibitors' sustained benefit for the common form of vision loss. A primary author explains the significance of the new findings.

New data show the highest quintile of census-reported parental income is far more represented among future physicians than lower income levels, regardless of race.

USPSTF experts noted a need for research into the benefits and harms of screening adults and adolescents without signs or symptoms.

Findings suggest mortality risk from the respiratory virus is twice greater among adults with CHF.

As influenza A(H3N2) remains the most prevalent subtype in the US, investigators estimated the available flu shot is not significantly preventing positive cases.

Trauma patients and patients treated with combination ABX therapy were at an increased risk of C difficile infections.

Research from Wake Forest shows patients are more comfortable sharing concerning matters when screened on a tablet app compared with speaking to a nurse.

While orders for C difficile toxin tests dropped significantly, the negative test rates did not differ much in recipients of solid organ transplantations.

The risk of death during, or shortly after pregnancy, was almost 3 times higher for Black women than for White women. Risk increased with age resulting in Black women 40 or over making up the majority of maternal deaths in 2020.

Experts from the Violence Intervention Advocacy Program of the Boston Medical Center share insight from their research examining the spike of violence observed early in the COVID-19 pandemic.

Patients with diarrhea did have longer hospital stays than patients without diarrhea.

The University of Colorado expert joins for a 5-part interview on making sense of the boom of new agents and care strategies.

The Yale Associate Chief of Cardiovascular Medicine discusses improved use of available drug classes, as well as the potential approval for omecamtiv mecarbil.

From a couple of novel heart failure treatments to a promising dual receptor agonist, here's a rundown of expected pipeline news this year in heart disease.

The absolute survival rate observed for US patients with IHCA and COVID-19 was 11.9%.

New recommendations were released by ACR and AAHKS regarding perioperative management of antirheumatic medications for patients with rheumatic diseases undergoing these procedures.